SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-000142
Filing Date
2022-01-04
Accepted
2022-01-04 08:28:13
Documents
14
Period of Report
2022-01-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K espr-20220104.htm   iXBRL 8-K 44268
2 EX-10.1 ex101generalcounselemploym.htm EX-10.1 78876
3 EX-99.1 ex991generalcounselhirepre.htm EX-99.1 8202
  Complete submission text file 0001628280-22-000142.txt   294897

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20220104.xsd EX-101.SCH 1927
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20220104_lab.xml EX-101.LAB 24993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20220104_pre.xml EX-101.PRE 13202
8 EXTRACTED XBRL INSTANCE DOCUMENT espr-20220104_htm.xml XML 11023
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 22504160
SIC: 2834 Pharmaceutical Preparations